Get the Stockscreener App
5.07
36.66%
1.36
After Hours:
4.95
-0.12
-2.37%
Co Diagnostics Inc stock is traded at $5.07, with a volume of 9.75M.
It is up +36.66% in the last 24 hours and up +200.00% over the past month.
Co-Diagnostics Inc is a molecular diagnostics company. The company develops, manufactures, licenses, and commercializes reagents used for diagnostic tests that function via the detection and/or analysis of nucleic acid molecules (DNA or RNA), including molecular tools for detection of infectious diseases. CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and others. The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.
See More
Previous Close:
$3.71
Open:
$3.355
24h Volume:
9.75M
Relative Volume:
2.03
Market Cap:
$18.26M
Revenue:
$418.20K
Net Income/Loss:
$-46.90M
P/E Ratio:
-0.2096
EPS:
-24.1892
Net Cash Flow:
$-29.84M
1W Performance:
+294.55%
1M Performance:
+200.00%
6M Performance:
-64.22%
1Y Performance:
-87.42%
1-Day Range:
$3.19
$5.38
1-Week Range:
$1.32
$5.38
52-Week Range:
$1.26
$5.38
Co Diagnostics Inc Stock (CODX) Company Profile
Name
Co Diagnostics Inc
Sector
Industry
Phone
(801) 438-1036
Address
2401 S FOOTHILL DRIVE, SALT LAKE CITY
Compare CODX vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CODX
Co Diagnostics Inc
|
5.07 | 13.37M | 418.20K | -46.90M | -29.84M | -24.19 |
ABT
Abbott Laboratories
|
87.41 | 152.88B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
316.48 | 120.18B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
78.60 | 100.34B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
57.78 | 84.95B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
85.78 | 47.91B | 6.30B | 1.07B | 1.09B | 1.8406 |
Co Diagnostics Inc Stock (CODX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-12-22 | Downgrade | Sidoti | Buy → Neutral |
| Dec-29-21 | Initiated | Sidoti | Buy |
| Mar-29-21 | Downgrade | Maxim Group | Buy → Hold |
| May-20-20 | Upgrade | Maxim Group | Hold → Buy |
| May-18-20 | Reiterated | H.C. Wainwright | Buy |
| Mar-09-20 | Reiterated | H.C. Wainwright | Buy |
| Mar-03-20 | Downgrade | Maxim Group | Buy → Hold |
View All
Co Diagnostics Inc Stock (CODX) Latest News
Point-Of-Care Virus Testing - Trend Hunter
Why Did CODX Stock Nearly Double In Value Today? - Stocktwits
Co-Diagnostics develops Ebola assay strategy following WHO emergency alert (CODX) - MSN
Co-Diagnostics Analyst Ratings and Price Targets | NASDAQ:CODX - Benzinga
Co-Diagnostics (CODX) Q1 2026 Earnings Transcript - AOL.com
Co-Diagnostics Develops Strategy for Ebola Bundibugyo Virus Assay - Clinical Lab Products
$Co-diagnostics (CODX.US)$ - Moomoo
CODX Stock Pops As Co-Diagnostics Targets MENA Growth - StocksToTrade
CODX Stock Jumps As Saudi Facility And Ebola Assay Fuel Momentum - timothysykes.com
Co-Diagnostics Announces $3 Million Private Placement Financing - TipRanks
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Co-Diagnostics Raises $3.0 Million in Private Placement; Investors Get Registration Rights; Maxim Engaged - TradingView
Co-Diagnostics (NASDAQ: CODX) prices $3M private placement with warrants - Stock Titan
What's going on with Co-Diagnostics stock Wednesday? - MSN
What's Going On With Co-Diagnostics Stock Wednesday?Co-Diagnostics (NASDAQ:CODX) - Benzinga
Co-Diagnostics, Inc. Commemorates Third Anniversary of the Compl - GuruFocus
Co-Diagnostics jumps 11%, raises $3M privately - MSN
Co-Diagnostics Jumps; $3 Million Deal Looms - TechStock²
Co-Diagnostics (CODX) Secures $3M in Private Placement, Stock Su - GuruFocus
Co-Diagnostics announces $3 million private placement By Investing.com - Investing.com South Africa
Co-Diagnostics announces $3 million private placement - Investing.com UK
Co-Diagnostics: Offering Expected to Close on or About May 21 >CODX - Moomoo
Co-Diagnostics plans $3M deal for over 1.6M shares and 5-year warrants - Stock Titan
Co-Diagnostics Announces $3.0 Million Private Placement Priced At-The-Market Under Nasdaq Rules - The Herald Journal
Press Release: Co-Diagnostics Announces $3.0 Million Private Placement Priced At-The-Market Under Nasdaq Rules - Moomoo
Co-Diagnostics (CODX) Advances Ebola Testing Amid Outbreak Conce - GuruFocus
Co-Diagnostics Stock Surges on Ebola Assay News — The Fine Print Is Big - TechStock²
Why is Co Diagnostics stock surging today? By Investing.com - Investing.com Nigeria
Why is Co Diagnostics stock surging today? - Investing.com UK
Diagnostic Platform Jumps as Ebola Response Readiness Takes Center Stage - The Globe and Mail
Co-Diagnostics shares surge as company touts Bundibugyo Ebola assay strategy amid outbreak - Quiver Quantitative
Co-Diagnostics Develops Ebola Assay Strategy Following WHO Emergency Alert (CODX) - Yahoo Finance
CODX Stock Jumps As Saudi CoMira Facility Signals Expansion - StocksToTrade
CODX Stock Jumps As Saudi CoMira Facility Moves To Execution - timothysykes.com
Co-Diagnostics Develops Ebola Assay Strategy Following Recent Global Outbreak Alert – Company Announcement - Financial Times
Co-Diagnostics, Inc. announced that it expects to receive $3 million in funding - marketscreener.com
Co-Diagnostics, Inc.Common Stock (NQ: CODX - The Chronicle-Journal
Co-Diagnostics, Inc. to Host Booth and Discuss Advancing POC/OTC - GuruFocus
[EFFECT] Co-Diagnostics, Inc. SEC Filing - Stock Titan
Co-Diagnostics reports net loss of USD 9.1M in Q1 2026 - Medical Buyer
Co-Diagnostics anticipates filing FDA 510(k) in the third quarter as CoSara expands TAM to approximately $13B - MSN
Co-Diagnostics, Inc. (NASDAQ:CODX) Q1 2026 Earnings Call Transcript - Insider Monkey
Co Diagnostics Inc Stock (CODX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.22%
1.41%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):